news
All
Company News
Press Releases
Scientific Announcements
Investment News
Feb 17, 2026 |
Press Releases
EpitogenX and Attomarker Sign Strategic Co-Development Agreement
Feb 10, 2026 |
Investment News
What an Acceleration Round means for Attomarker at this stage
May 29, 2024 |
Company News
Attomarker has been selected as one of the companies by Innovate UK
Nov 29, 2023 |
Investment News
Attomarker is Revolutionising Diagnostic Technology and the Potential of Big Data
Oct 12, 2020 |
Scientific Announcements
Were White House COVID victims lulled into false sense of security by current antigen tests?
Sep 8, 2020 |
Scientific Announcements
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Sep 7, 2020 |
Scientific Announcements
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Aug 10, 2020 |
Scientific Announcements
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Jul 8, 2020 |
Scientific Announcements
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Jun 16, 2020 |
Scientific Announcements
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Mar 24, 2020 |
Scientific Announcements
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Jan 15, 2020 |
Scientific Announcements
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
Nov 15, 2019 |
Scientific Announcements
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Nov 8, 2019 |
Scientific Announcements
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Sep 9, 2019 |
Scientific Announcements
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Sep 2, 2019 |
Scientific Announcements
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More
Oct 12, 2020 |
Scientific Announcements
Were White House COVID victims lulled into false sense of security by current antigen tests?
Sep 8, 2020 |
Scientific Announcements
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Sep 7, 2020 |
Scientific Announcements
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Aug 10, 2020 |
Scientific Announcements
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Jul 8, 2020 |
Scientific Announcements
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Jun 16, 2020 |
Scientific Announcements
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
Mar 24, 2020 |
Scientific Announcements
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
Jan 15, 2020 |
Scientific Announcements
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
Nov 15, 2019 |
Scientific Announcements
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Nov 8, 2019 |
Scientific Announcements
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Sep 9, 2019 |
Scientific Announcements
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Sep 2, 2019 |
Scientific Announcements
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More
Feb 10, 2026 |
Investment News
What an Acceleration Round means for Attomarker at this stage
Nov 29, 2023 |
Investment News